Biotech Biz 

​Why Biotech Biz

​

Biotech Biz is a newly created consortium of highly experienced clinical operations experts providing strategic and hands-on clinical operations services to optimise early-phase clinical trial set-up and execution. Founded by a veteran Clinical Operations Director and Functional Lead with three decades of hands-on experience across biotech, pharmaceutical and CRO environments, Biotech Biz brings senior clinical operations expertise to growing biotechnology companies when and where it is needed.

​

A Changing Clinical Trial Landscape

​

The clinical development landscape is changing. ICH E6(R3) places greater emphasis on Quality by Design, critical-to-quality factors, proportionate risk management and ensuring that the right people, expertise and resources are in place from the outset.

​

For growing biotech companies, translating these principles into practice can be challenging. Capital is limited, timelines are tight and every milestone matters, while regulatory requirements and increasingly complex protocol designs place additional demands on already limited resources. At the same time, companies need to demonstrate that robust frameworks, due diligence, partner selection and sponsor oversight are in place.

​

The Gap We See

​

Biotech companies need access to experienced clinical operations expertise without necessarily having the resources or need to build a large internal function.

​

Biotech Biz fills this gap. We provide agile, flexible and cost-effective access to senior clinical operations expertise, helping biotech companies establish the frameworks, due diligence, partner selection and oversight needed to manage risk, demonstrate effective sponsor oversight and embed quality and operational efficiency from the start.

​

Independent Oversight: The Strategic Difference

​

Many lean biotechs rely on CRO Functional Service Provider (FSP) models to provide the operational expertise they need. While FSP models can provide valuable resources, they do not necessarily provide the independent perspective or senior strategic oversight required to challenge and oversee the CRO effectively.

​

Biotech Biz works exclusively for the sponsor, providing an independent perspective across CRO and vendor selection, due diligence, governance, performance, risks, timelines, costs and quality.

 

Rather than adding another layer of delivery resource, Biotech Biz provides senior clinical operations expertise on the sponsor side of the table — bringing decades of experience to the decisions that can determine whether a study is set up for success.

​

The Biotech Biz Difference

​

• Independent: We work for the biotech, not the CRO, allowing us to objectively assess performance, challenge assumptions and escalate concerns.

• Senior: Access to experienced clinical operations leaders who have managed complex global Phase I–II studies and built clinical operations functions — without the cost of employing a full-time senior leader.

• Flexible: Services can be scaled to the needs of your programme, whether you need support with CRO selection, study start-up, operational planning, vendor oversight, risk management or ongoing study governance.

• Practical: We don't just provide recommendations. We help establish the frameworks, processes and oversight mechanisms needed to make them work in practice.

• Cost-effective: Biotech companies gain access to senior expertise without committing to the fixed cost of building a large internal clinical operations function.​

​​

​​​​​